Figure 3

Effect of EGCG and miR-126 on cell cycle in osteosarcoma cells. (A) The representative images of flow cytometry analysis using PI staining. (B) The cell cycle distribution in U2OS cells infected with anti-miR-126, pre-miR-126, or treated with RAPA, DDP or EGCG. ^*P <0.05 vs. indicated group; ^aP <0.05 vs. Con alone group; ^bP <0.05 vs. anti-miR-126 alone group; ^cP <0.05 vs. pre-miR-126 alone group. Con, control; DDP, cisplatin; EGCG, epigallocatechin-3-gallate; miR, microRNA; PI, propidium iodide; RAPA, rapamycin.